JP2011098056A - 犬の疾病リスク評価方法 - Google Patents
犬の疾病リスク評価方法 Download PDFInfo
- Publication number
- JP2011098056A JP2011098056A JP2009254442A JP2009254442A JP2011098056A JP 2011098056 A JP2011098056 A JP 2011098056A JP 2009254442 A JP2009254442 A JP 2009254442A JP 2009254442 A JP2009254442 A JP 2009254442A JP 2011098056 A JP2011098056 A JP 2011098056A
- Authority
- JP
- Japan
- Prior art keywords
- body fat
- fat percentage
- dog
- risk
- cancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000000034 method Methods 0.000 title claims abstract description 36
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title claims abstract description 26
- 201000010099 disease Diseases 0.000 title claims abstract description 25
- 210000000577 adipose tissue Anatomy 0.000 claims abstract description 93
- 241000282472 Canis lupus familiaris Species 0.000 claims abstract description 71
- 206010028980 Neoplasm Diseases 0.000 claims abstract description 33
- 235000005911 diet Nutrition 0.000 claims abstract description 26
- 230000037213 diet Effects 0.000 claims abstract description 22
- 238000011282 treatment Methods 0.000 claims abstract description 21
- 201000011510 cancer Diseases 0.000 claims abstract description 15
- 229920001685 Amylomaize Polymers 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims description 23
- 238000012502 risk assessment Methods 0.000 claims description 3
- 238000011156 evaluation Methods 0.000 claims description 2
- 241000282465 Canis Species 0.000 claims 1
- 230000000378 dietary effect Effects 0.000 abstract description 4
- 230000002349 favourable effect Effects 0.000 abstract 1
- 238000007726 management method Methods 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- XLYOFNOQVPJJNP-ZSJDYOACSA-N Heavy water Chemical compound [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 10
- 230000037396 body weight Effects 0.000 description 10
- 229920000856 Amylose Polymers 0.000 description 7
- 230000036541 health Effects 0.000 description 6
- 235000012054 meals Nutrition 0.000 description 6
- 238000004364 calculation method Methods 0.000 description 5
- 239000003925 fat Substances 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 208000008589 Obesity Diseases 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- 235000011888 snacks Nutrition 0.000 description 4
- 229920002261 Corn starch Polymers 0.000 description 3
- 241001465754 Metazoa Species 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 239000008120 corn starch Substances 0.000 description 3
- 150000002632 lipids Chemical class 0.000 description 3
- 238000005259 measurement Methods 0.000 description 3
- 230000007935 neutral effect Effects 0.000 description 3
- 235000016709 nutrition Nutrition 0.000 description 3
- 208000010772 Dog disease Diseases 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 238000007796 conventional method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 238000003113 dilution method Methods 0.000 description 2
- 208000000509 infertility Diseases 0.000 description 2
- 230000036512 infertility Effects 0.000 description 2
- 231100000535 infertility Toxicity 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 210000005075 mammary gland Anatomy 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 238000007619 statistical method Methods 0.000 description 2
- 230000004580 weight loss Effects 0.000 description 2
- 241000824799 Canis lupus dingo Species 0.000 description 1
- 235000019750 Crude protein Nutrition 0.000 description 1
- 240000005595 Echinocereus dasyacanthus Species 0.000 description 1
- 235000008314 Echinocereus dasyacanthus Nutrition 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 108091093126 WHP Posttrascriptional Response Element Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000003579 anti-obesity Effects 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 235000019577 caloric intake Nutrition 0.000 description 1
- 208000035269 cancer or benign tumor Diseases 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000019784 crude fat Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000037228 dieting effect Effects 0.000 description 1
- 230000005713 exacerbation Effects 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000002550 fecal effect Effects 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 208000021267 infertility disease Diseases 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 208000030175 lameness Diseases 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000006996 mental state Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000007659 motor function Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000001613 neoplastic effect Effects 0.000 description 1
- 235000021590 normal diet Nutrition 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000003938 response to stress Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 235000021076 total caloric intake Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 230000037221 weight management Effects 0.000 description 1
Landscapes
- Feed For Specific Animals (AREA)
- Fodder In General (AREA)
Abstract
【解決手段】犬の体脂肪率を測定し、体脂肪率が35%以上の場合と35%未満に区分し、前者の場合には腫瘍又は癌発症のリスクが高いと評価する方法である。当該リスクが高いと評価された犬には体脂肪率が35%未満となる食餌管理が施される予防処置を提供する。該食餌管理がジアシルグリセライド及び/又はハイアミロースでんぷんを含む食餌を投与することを含むことが好適である。
【選択図】なし
Description
〔体脂肪率の測定方法〕
絶食12時間の犬に対して採血と体重測定を行った。そのときの重水濃度をCpre、体重をWpreとする。その後、試験に供される犬の体重に0.2を乗じた量の重水を注入し、2時間経過後、採血と体重測定を行った。そのときの重水濃度をCpre、体重をWpostとする。得られた数値を以下の式に挿入することによって体脂肪率を算出した。
4歳、オスのチワワ(体重4.55kg、体脂肪率39.3%、A=96)に対して、205kcal/食餌となる量の試験食を与えた。試験前は体脂肪率39.3%であったのが、8週間後は33.4%になった。
3歳、メスのミニチュアダックスフント(体重6.45kg、体脂肪率32.8%、A=103)に対して、308kcal/食餌となる量の試験食を与えた。試験前は体脂肪率32.8%であったのが、8週間後には30.0%となった。
2歳、メスのヨークシャーテリア(体重3.65kg、体脂肪率28.3%、A=78)に対して、160kcal/食餌となる量の試験食を与えた。試験前の体脂肪率は28.3%であったのが、8週間後には24.1%となった。
Claims (6)
- 犬の体脂肪率を測定し、体脂肪率が35%以上の場合と35%未満の場合に区分し、35%以上の場合には腫瘍又は癌の発症リスクが高いと判断する、犬の疾病発生リスク評価方法。
- 請求項1記載の疾病発生リスク評価方法によって発症リスクが高いと判断された未病の犬に対して、体脂肪率が35%未満となる処置を施す、犬の腫瘍又は癌の発症リスク低減方法。
- 請求項1記載の疾病リスク評価方法によって発症リスクが低いと判断された体脂肪率が35%未満である犬に対して、体脂肪率を35%未満に維持する処置を施す、犬の腫瘍又は癌の発症リスク低減方法。
- 前記処置が食餌管理によるものであって、該食餌管理がジアシルグリセライド及び/又はハイアミロースでんぷんを含む食餌を投与することを含む、請求項2又は3記載の犬の腫瘍又は癌の発症リスク低減方法。
- 前記処置が食餌のカロリー量を制御することを含む食餌管理である、請求項2又は3記載の犬の腫瘍又は癌の発症リスク低減方法。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009254442A JP5513851B2 (ja) | 2009-11-05 | 2009-11-05 | 犬の腫瘍又は癌の発症リスク低減方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2009254442A JP5513851B2 (ja) | 2009-11-05 | 2009-11-05 | 犬の腫瘍又は癌の発症リスク低減方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2011098056A true JP2011098056A (ja) | 2011-05-19 |
JP5513851B2 JP5513851B2 (ja) | 2014-06-04 |
Family
ID=44189733
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009254442A Active JP5513851B2 (ja) | 2009-11-05 | 2009-11-05 | 犬の腫瘍又は癌の発症リスク低減方法 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP5513851B2 (ja) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015221001A (ja) * | 2014-05-22 | 2015-12-10 | 辻製油株式会社 | 脂質の生体内沈着抑制剤、飼料および飼育方法 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005000074A (ja) * | 2003-06-11 | 2005-01-06 | Tanita Corp | 犬用健康管理装置 |
JP2007195931A (ja) * | 2005-03-25 | 2007-08-09 | Kao Corp | ペット用体脂肪測定具 |
JP2009118758A (ja) * | 2007-11-13 | 2009-06-04 | Kao Corp | ペットの体重管理方法 |
JP2009159856A (ja) * | 2007-12-28 | 2009-07-23 | Kao Corp | ペットフード |
-
2009
- 2009-11-05 JP JP2009254442A patent/JP5513851B2/ja active Active
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005000074A (ja) * | 2003-06-11 | 2005-01-06 | Tanita Corp | 犬用健康管理装置 |
JP2007195931A (ja) * | 2005-03-25 | 2007-08-09 | Kao Corp | ペット用体脂肪測定具 |
JP2009118758A (ja) * | 2007-11-13 | 2009-06-04 | Kao Corp | ペットの体重管理方法 |
JP2009159856A (ja) * | 2007-12-28 | 2009-07-23 | Kao Corp | ペットフード |
Non-Patent Citations (2)
Title |
---|
古瀬 充宏: ""イヌの肥満とボディコンディションスコア"", ペット栄養学会誌 第10巻 第1号, JPN6013061300, 10 April 2007 (2007-04-10), pages 39 - 41, ISSN: 0002702612 * |
大川 雅之 他: ""体脂肪計を用いた肥満犬のための新しい減量プログラム"", 第27回動物臨床医学会年次大会プロシーディング, JPN6013061303, 17 November 2006 (2006-11-17), pages 281 - 282, ISSN: 0002702613 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015221001A (ja) * | 2014-05-22 | 2015-12-10 | 辻製油株式会社 | 脂質の生体内沈着抑制剤、飼料および飼育方法 |
Also Published As
Publication number | Publication date |
---|---|
JP5513851B2 (ja) | 2014-06-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Witzel et al. | Use of a novel morphometric method and body fat index system for estimation of body composition in overweight and obese dogs | |
Morgan et al. | Treatment of equine metabolic syndrome: a clinical case series | |
German et al. | Long-term follow-up after weight management in obese dogs: the role of diet in preventing regain | |
Brownbill et al. | Association between dietary conjugated linoleic acid and bone mineral density in postmenopausal women | |
Patterson et al. | The effect of gilt age at first estrus and breeding on third estrus on sow body weight changes and long-term reproductive performance | |
Bauer et al. | Obesity in rhesus and cynomolgus macaques: a comparative review of the condition and its implications for research | |
RU2569698C2 (ru) | Способ управления состоянием массы тела у животного | |
Kearney et al. | Genotype× environment interaction for grazing versus confinement. I. Production traits | |
Shoveller et al. | Trained vs untrained evaluator assessment of body condition score as a predictor of percent body fat in adult cats | |
Søndergaard et al. | Genetic parameters of production, feed intake, body weight, body composition, and udder health in lactating dairy cows | |
Bunter et al. | Selection to reduce residual feed intake in pigs produces a correlated response in juvenile insulin-like growth factor-I concentration | |
Madson et al. | Rickets: case series and diagnostic review of hypovitaminosis D in swine | |
Den Hertog et al. | Results of non‐selective adrenocorticolysis by o, p'‐DDD in 129 dogs with pituitary‐dependent hyperadrenocorticism | |
Zebeli et al. | A model to optimise the requirements of lactating dairy cows for physically effective neutral detergent fibre | |
Connor et al. | Triennial lactation symposium: Opportunities for improving milk production efficiency in dairy cattle | |
JP5086037B2 (ja) | ペットの体重管理方法 | |
TW200407084A (en) | Dietary method for modulating glucose metabolism and associated conditions and increasing longevity | |
Calderón Díaz et al. | Age at puberty, ovulation rate, and uterine length of developing gilts fed two lysine and three metabolizable energy concentrations from 100 to 260 d of age | |
Vandendriessche et al. | First detailed nutritional survey in a referral companion animal population | |
German et al. | Use of starting condition score to estimate changes in body weight and composition during weight loss in obese dogs | |
Franchi et al. | Dairy cows fed a low energy diet before dry-off show signs of hunger despite ad libitum access | |
Wiechers et al. | Analysis of hair cortisol as an indicator of chronic stress in pigs in two different farrowing systems | |
King et al. | Milk yield relative to supplement intake and rumination time differs by health status for fresh cows milked with automated systems | |
Power et al. | Diet, digestion and energy intake in captive common marmosets (Callithrix jacchus): research and management implications | |
Friedrich et al. | Test–retest reliability of the Welfare Quality Assessment protocol for pigs applied to sows and piglets. Part 2. Assessment of the principles good feeding, good housing, and good health |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20120913 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20131217 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140205 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20140304 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20140328 |
|
R151 | Written notification of patent or utility model registration |
Ref document number: 5513851 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R151 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |